ड प स ओ 2013 क प र 4 क तहत, अग त 2015 क आ कड़ क आध रत, म य क स गणन

Size: px
Start display at page:

Download "ड प स ओ 2013 क प र 4 क तहत, अग त 2015 क आ कड़ क आध रत, म य क स गणन"

Transcription

1 ड प स ओ 2013 क प र 4 क तहत, अग त 2015 क आ कड़ क आध रत, म य क स गणन Number of Companies consisting of Market Share of 1% & Above ONDANSETRON 4 MG Tablet Per Tablet Sum of value considered for price calculation (in Lakhs) 10, Sum of PTR unit considered for price calculation Number of s considered 18 Average PTR 3.85 Add : 16% Retailer Margin 0.62 Ceiling Price (without local taxes) 4.47 % Reduction with compared to Highest Price 12.30% WPI Reduction wef % 0.12 Final Ceiling Price (without local taxes) 4.35 Minimum Price 2.51 S.O. 619(E) dated Maximum Price 4.39 Ceiling Price as Per Tablet Average of all considered 3.85 Derived PTR 4.53 Ceiling Price 4.47 S. Unique Composition as प क ववरण क पन TOTAL 1,08,64,52, % Brandwis e Y=Yes O% ) N=No Price Unit Price Unit ONDANSETRON A4A2 NAUCID 4 MG TABLET 6 NAUCID ABBOTT HEALTHCARE PVT. LTD 4 MG 6 TABLET ,46, % 0.37% N ONDANSETRON A4A2 NAUCID 4 MG TABLET MD 10 NAUCID ABBOTT HEALTHCARE PVT. LTD 4 MG 10 TABLET MD ,44, % 0.37% N ONDANSETRON A4A2 ONDACE 4 MG TABLET 10 ONDACE ADCOCK INGRAM HEALTHCARE PVT LTD 4 MG 10 TABLET ,44, % 0.56% N ONDANSETRON A4A2 ONDACE 4 MG TABLET MD 10 ONDACE ADCOCK INGRAM HEALTHCARE PVT LTD 4 MG 10 TABLET MD ,17, % 0.56% N ONDANSETRON A4A2 VOMICURE 4 MG TABLET MD 10 VOMICURE AKUMENTIS HEALTHCARE LTD 4 MG 10 TABLET MD ,78, % 0.26% N ONDANSETRON A4A2 ONDANBIC 4 MG TABLET MD 10 ONDANBIC ALEMBIC LTD 4 MG 10 TABLET MD ,44, % 0.42% N ONDANSETRON A4A2 ONDEM 4 MG TABLET 10 ONDEM ALKEM LABORATORIES LTD. 4 MG 10 TABLET ,74,60, % 35.78% Y ONDANSETRON A4A2 ONDEM 4 MG TABLET MD 10 ONDEM ALKEM LABORATORIES LTD. 4 MG 10 TABLET MD ,12,75, % 35.78% Y ONDANSETRON A4A2 VOMIGO(AURUM) 4 MG TABLET MD 10 VOMIGO(AURUM) AURUM LIFE SCIENCE PVT. LTD. 4 MG 10 TABLET MD , % 0.01% N ONDANSETRON A4A2 ANSET 4 MG TABLET 10 ANSET BENNET PHARMACEUTICALS LIMITED 4 MG 10 TABLET ,34, % 7.54% Y ONDANSETRON A4A2 ANSET MD 4 MG TABLET 10 ANSET BENNET PHARMACEUTICALS LIMITED 4 MG 10 TABLET ,79,46, % 7.54% Y ONDANSETRON A4A2 OND MD 4 MG TABLET MD 10 OND MD BESTOCHEM FORMULATIONS (I) LTD 4 MG 10 TABLET MD ,54, % 0.24% N ONDANSETRON A4A2 ETERNA 4 MG TABLET MD 10 ETERNA BLUE CROSS LABORATORIES LTD 4 MG 10 TABLET MD ,63, % 0.85% N ONDANSETRON A4A2 EMITINO 4 MG TABLET MD 6 EMITINO CACHET PHARMACEUTICALS PVT LTD 4 MG 6 TABLET MD ,44, % 0.52% N ONDANSETRON A4A2 EMITINO 4 MG TABLET MD 10 EMITINO CACHET PHARMACEUTICALS PVT LTD 4 MG 10 TABLET MD ,46, % 0.52% N ONDANSETRON A4A2 ONVIN 4 MG TABLET MD 10 ONVIN CADILA PHARMACEUTICALS LTD 4 MG 10 TABLET MD , % 0.01% N ONDANSETRON A4A2 EMESET MD 4 MG TABLET MD 10 EMESET CIPLA LTD. 4 MG 10 TABLET MD ,07, % 11.57% Y ONDANSETRON A4A2 EMSET 4 MG TABLET 10 EMSET CIPLA LTD. 4 MG 10 TABLET ,22, % 0.30% N ONDANSETRON A4A2 EMESET 4 MG TABLET 10 EMESET CIPLA LTD. 4 MG 10 TABLET ,55,64, % 11.57% Y ONDANSETRON A4A2 ONTIC MD 4 MG TABLET MD 10 ONTIC CORONA 4 MG 10 TABLET MD ,69, % 0.86% N ONDANSETRON A4A2 NAV 4 MG TABLET 10 NAV ERIS LIFE SCIENCES PVT LTD 4 MG 10 TABLET ,29, % 0.03% N ONDANSETRON A4A2 VOMISAVE 4 MG TABLET 10 VOMISAVE ERIS LIFE SCIENCES PVT LTD 4 MG 10 TABLET ,34, % 0.30% N ONDANSETRON A4A2 VORAST 4 MG TABLET MD 10 VORAST FDC LTD. 4 MG 10 TABLET MD ,56, % 0.24% N ONDANSETRON A4A2 ISV 4 MG TABLET MD 10 ISV GALPHA LABORATORIES LTD 4 MG 10 TABLET MD ,21,75, % 1.12% Y ONDANSETRON A4A2 NVNIL 4 MG TABLET 10 NVNIL GENESIS REMEDIES PVT LTD 4 MG 10 TABLET ,45, % 0.01% N ONDANSETRON A4A2 NO EMIS 4 MG TABLET 6 NO EMIS GRACIOUS PHARMACEUTICALS 4 MG 6 TABLET ,02, % 0.01% N ONDANSETRON A4A2 EMETON MD 4 MG TABLET 10 EMETON IATROS PHARMACEUTICALS PVT. LTD. 4 MG 10 TABLET ,28, % 0.03% N ONDANSETRON A4A2 EMITUS 4 MG TABLET 10 EMITUS ICARUS HEALTHCARE PRIMUS 4 MG 10 TABLET ,31, % 0.08% N ONDANSETRON A4A2 ODANSE 4 MG TABLET MD 10 ODANSE INDCHEMIE HEALTH SPECIALITIES PVT. LTD. 4 MG 10 TABLET MD ,11, % 0.04% N ONDANSETRON A4A2 VOMISET 4 MG TABLET 10 VOMISET INDI PHARMA 4 MG 10 TABLET ,17, % 1.03% Y ONDANSETRON A4A2 VOMISET MD 4 MG TABLET MD 10 VOMISET INDI PHARMA 4 MG 10 TABLET MD ,02, % 1.03% Y ONDANSETRON A4A2 EMLESS 4 MG TABLET 10 EMLESS INDIAN DRUG & PHARMACEUTICALS LTD (IDPL) 4 MG 10 TABLET ,28, % 0.01% N ONDANSETRON A4A2 SPERONDEN MD 4 MG TABLET MD 10 SPERONDEN INDOCO REMEDIES LTD 4 MG 10 TABLET MD ,71, % 0.10% N ONDANSETRON A4A2 SPERONDEN 4 MG TABLET 10 SPERONDEN INDOCO REMEDIES LTD 4 MG 10 TABLET ,53, % 0.10% N ONDANSETRON A4A2 VOMIHALT 4 MG TABLET MD 10 VOMIHALT IPCA LABORATORIES PVT LTD. 4 MG 10 TABLET MD ,74, % 0.44% N ONDANSETRON A4A2 PERISET 4 MG TABLET 10 PERISET IPCA LABORATORIES PVT LTD. 4 MG 10 TABLET ,58, % 3.45% Y ONDANSETRON A4A2 PERISET MD 4 MG TABLET MD 10 PERISET IPCA LABORATORIES PVT LTD. 4 MG 10 TABLET MD ,95,25, % 3.45% Y ONDANSETRON A4A2 VOMIRUN 4 MG TABLET 10 VOMIRUN JARUN PHARMACEUTICALS 4 MG 10 TABLET ,03, % 0.01% N ONDANSETRON A4A2 OMETIC 4 MG TABLET MD 10 OMETIC JUPITER PHARMACEUTICALS 4 MG 10 TABLET MD ,68, % 0.02% N 3.77

2 S. Unique Composition as प क ववरण क पन Brandwis e Y=Yes O% ) N=No Price Unit Price Unit 40 ONDANSETRON A4A2 ONKAM 4 MG TABLET MD 10 ONKAM KAMRON LABORATORIES 4 MG 10 TABLET MD ,48, % 0.07% N ONDANSETRON A4A2 DOMI UP 4 MG TABLET 10 DOMI UP LINCOLN PHARMACEUTICALS LTD 4 MG 10 TABLET ,26, % 0.07% N ONDANSETRON A4A2 ONDAMAC 4 MG TABLET 10 ONDAMAC MACLEODS PHARMACEUTICALS PVT.LTD 4 MG 10 TABLET ,13, % 1.03% Y ONDANSETRON A4A2 ONDAMAC 4 MG TABLET MD 10 ONDAMAC MACLEODS PHARMACEUTICALS PVT.LTD 4 MG 10 TABLET MD ,46, % 1.03% Y ONDANSETRON A4A2 VOMIKIND 4 MG TABLET MD 10 VOMIKIND MANKIND PHARMACEUTICALS LTD. 4 MG 10 TABLET MD ,73,56, % 17.24% Y ONDANSETRON A4A2 SET NV 4 MG TABLET 10 SET NV MAPRA LABORATORIES PVT. LTD 4 MG 10 TABLET ,18, % 0.03% N ONDANSETRON A4A2 NOEM 4 MG TABLET 10 NOEM MED MANOR ORGANICS PVT LTD. 4 MG 10 TABLET ,86, % 0.11% N ONDANSETRON A4A2 NOEM 4 MG TABLET MD 10 NOEM MED MANOR ORGANICS PVT LTD. 4 MG 10 TABLET MD ,28, % 0.11% N ONDANSETRON A4A2 OSET 4 MG TABLET 10 OSET MEDLEY PHARMACEUTICALS 4 MG 10 TABLET ,81, % 0.06% N ONDANSETRON A4A2 OSET 4 MG TABLET MD 10 OSET MEDLEY PHARMACEUTICALS 4 MG 10 TABLET MD ,05, % 0.06% N ONDANSETRON A4A2 ONMED 4 MG TABLET 10 ONMED MEDOZ PHARMA 4 MG 10 TABLET , % 0.01% N ONDANSETRON A4A2 EMEKULE 4 MG TABLET MD 10 EMEKULE MOLEKULE (IND)PVT LTD 4 MG 10 TABLET MD , % 0.01% N ONDANSETRON A4A2 ONDOC 4 MG TABLET 10 ONDOC MOREPEN LABORATORIES LIMITED 4 MG 10 TABLET ,24, % 0.02% N ONDANSETRON A4A2 NEOMIT 4 MG TABLET 10 NEOMIT NEON LABORATORIES LTD 4 MG 10 TABLET ,23, % 0.01% N ONDANSETRON A4A2 ONDET 4 MG TABLET 10 ONDET NEURON PHARMA (P) LTD 4 MG 10 TABLET ,01, % 0.06% N ONDANSETRON A4A2 ONSURGE 4 MG TABLET MD 10 ONSURGE OBSURGE PHARMA (P) LTD 4 MG 10 TABLET MD ,84, % 0.08% N ONDANSETRON A4A2 OZOTRON 4 MG TABLET 10 OZOTRON OZONE PHARMACEUTICALS 4 MG 10 TABLET , % 0.13% N ONDANSETRON A4A2 OZOTRON 4 MG TABLET MD 10 OZOTRON OZONE PHARMACEUTICALS 4 MG 10 TABLET MD ,94, % 0.13% N ONDANSETRON A4A2 ONDAPIL 4 MG TABLET MD 10 ONDAPIL PSYCHOTROPICS INDIA LTD 4 MG 10 TABLET MD ,13, % 0.01% N ONDANSETRON A4A2 VEGAS 4 MG TABLET 10 VEGAS REKVINA PHARMACEUTICALS 4 MG 10 TABLET ,91, % 0.02% N ONDANSETRON A4A2 ONDY MD 4 MG TABLET MD 10 ONDY MD RONYD HEALTH CARE PVT LTD 4 MG 10 TABLET MD ,42, % 0.07% N ONDANSETRON A4A2 PROSPECT MD 4 MG TABLET 10 PROSPECT SKYMAX LABORATORIES LTD. 4 MG 10 TABLET ,77, % 0.16% N ONDANSETRON A4A2 VOMIOF 4 MG TABLET 10 VOMIOF STADMED PVT. LTD 4 MG 10 TABLET ,30, % 0.02% N ONDANSETRON A4A2 VOMIKOOL 4 MG TABLET 10 VOMIKOOL STAUNCH PHARMACEUTICALS 4 MG 10 TABLET ,85, % 0.04% N ONDANSETRON A4A2 ZOFER 4 MG TABLET 10 ZOFER SUN PHARMA LABORATORIES LTD. 4 MG 10 TABLET ,87,47, % 10.71% Y ONDANSETRON A4A2 ZOFER MD 4 MG TABLET MD 10 ZOFER SUN PHARMA LABORATORIES LTD. 4 MG 10 TABLET MD ,75,98, % 10.71% Y ONDANSETRON A4A2 O M T 4 MG TABLET 10 O M T THRIFT PHARMACEUTICALS 4 MG 10 TABLET ,89, % 0.05% N ONDANSETRON A4A2 EMNIL MD 4 MG TABLET 10 EMNIL VILBERRY HEALTHCARE PVT LTD 4 MG 10 TABLET ,92, % 0.02% N ONDANSETRON A4A2 EMIGO 4 MG TABLET 10 EMIGO ZUVENTUS HEALTHCARE LTD 4 MG 10 TABLET ,11,74, % 3.80% Y ONDANSETRON A4A2 EMIGO MD 4 MG TABLET MD 10 EMIGO ZUVENTUS HEALTHCARE LTD 4 MG 10 TABLET MD ,01,13, % 3.80% Y

3 ड प स ओ 2013 क प र 4 क तहत, अग त 2015 क आ कड़ क आध रत, म य क स गणन Number of Companies consisting of Market Share of 1% & Above 10 Sum of value considered for price calculation (in Lakhs) Fluconazole 150 MG 150 MG Tablet Per Tablet Sum of PTR unit considered for price calculation Number of s considered 15 Average PTR 9.74 Add : 16% Retailer Margin 1.56 Ceiling Price (without local taxes) % Reduction with compared to Highest Price 29.16% WPI Reduction wef % 0.31 Final Ceiling Price (without local taxes) S. Unique Composition as प क ववरण Minimum Price 3.15 S.O. 619(E) dated Maximum Price Ceiling Price as Per Tablet Average of all considered 9.74 Derived PTR Ceiling Price क पन TOTAL 67,95,81, % FLUCONAZOLE J2A4 FLUCOS 150 MG TABLET 4 FLUCOS ADCOCK INGRAM HEALTHCARE PVT LTD 150 MG 4 TABLET ,40,00, % 5.00% Y FLUCONAZOLE J2A4 ADIFUNG 150 MG TABLET 1 ADIFUNG ADIPS LABORATORIES 150 MG 1 TABLET ,03, % 0.02% N FLUCONAZOLE J2A4 FLUCAZ 150 MG TABLET 1 FLUCAZ AGIO PHARMACEUTICALS 150 MG 1 TABLET ,46, % 0.02% N FLUCONAZOLE D1A17 EFCAN 150 MG TABLET 1 EFCAN AIGIS BIOTEC 150 MG 1 TABLET ,25, % 0.02% N FLUCONAZOLE J2A4 FLUCOSYN 150 MG TABLET 2 FLUCOSYN ALBATROSS HEALTH CARE PVT LTD 150 MG 2 TABLET ,38, % 0.13% N FLUCONAZOLE J2A4 FLUCOSYN 150 MG TABLET 1 FLUCOSYN ALBATROSS HEALTH CARE PVT LTD 150 MG 1 TABLET ,14, % 0.13% N FLUCONAZOLE J2A4 ALFLUCOZ 150 MG TABLET 1 ALFLUCOZ ALEMBIC LTD 150 MG 1 TABLET , % 0.01% N FLUCONAZOLE J2A4 FLUKEM 150 MG TABLET 1 FLUKEM ALKEM LABORATORIES LTD. 150 MG 1 TABLET ,90, % 0.06% N FLUCONAZOLE J2A4 AFFLU 150 MG TABLET 4 AFFLU APOSTLE REMEDIES 150 MG 4 TABLET , % 0.01% N FLUCONAZOLE J2A4 FLOZ 150 MG TABLET 1 FLOZ ARTEL LABORATORIES 150 MG 1 TABLET ,26, % 0.02% N FLUCONAZOLE J2A4 ATCAN (ATOPIC) 150 MG TABLET 1 ATCAN (ATOPIC) ATOPIC LABORATORIES 150 MG 1 TABLET ,35, % 0.12% N FLUCONAZOLE J2A4 FLZ 150 MG TABLET 1 FLZ AXON HEALTH CARE LTD 150 MG 1 TABLET , % 0.01% N FLUCONAZOLE J2A4 FUNGID BEST 150 MG TABLET 1 FUNGID BEST BESTOCHEM FORMULATIONS (I) LTD 150 MG 1 TABLET ,94, % 1.47% Y FLUCONAZOLE J2A4 FUNGID 150 MG TABLET 1 FUNGID BESTOCHEM FORMULATIONS (I) LTD 150 MG 1 TABLET ,70, % 1.47% Y FLUCONAZOLE J2A4 CANZOL (BSP) 150 MG TABLET 4 CANZOL (BSP) BSP PHARMACEUTICALS 150 MG 4 TABLET ,35, % 0.02% N FLUCONAZOLE J2A4 FLUCONA 150 MG TABLET 1 FLUCONA CALIBAR PHARMACEUTICALS 150 MG 1 TABLET ,44, % 0.02% N FLUCONAZOLE J2A4 CANFREE 150 MG TABLET 1 CANFREE CHEM + MED PHARMACEUTICALS 150 MG 1 TABLET ,51, % 0.02% N FLUCONAZOLE J2A4 FUNGICIP 150 MG TABLET 1 FUNGICIP CIPLA LTD. 150 MG 1 TABLET , % 0.74% N FLUCONAZOLE J2A4 FLUKA 150 MG TABLET 1 FLUKA CIPLA LTD. 150 MG 1 TABLET ,79, % 0.74% N FLUCONAZOLE J2A4 FLUTY 150 MG TABLET 1 FLUTY COXSWAIN HEALTHCARE 150 MG 1 TABLET ,65, % 0.02% N FLUCONAZOLE J2A4 LODO 150 MG TABLET 1 LODO DR. JOHNS LABORATORIES PVT LTD 150 MG 1 TABLET ,34, % 0.08% N FLUCONAZOLE J2A4 FUNSPOR 150 MG TABLET 1 FUNSPOR DWD PHARMACEUTICALS LTD 150 MG 1 TABLET ,16, % 0.86% N FLUCONAZOLE J2A4 NUCONAZOLE 150 MG TABLET 1 NUCONAZOLE EMBIOTIC LAB 150 MG 1 TABLET ,09, % 0.02% N FLUCONAZOLE J2A4 FUNGIBID 150 MG TABLET 1 FUNGIBID ENDOCARE INDIA 150 MG 1 TABLET ,38, % 0.02% N FLUCONAZOLE J2A4 ZOCON ST 150 MG TABLET 2 ZOCON FDC LTD. 150 MG 2 TABLET ,06, % 22.91% Y FLUCONAZOLE J2A4 ZOCON 150 MG TABLET 2 ZOCON FDC LTD. 150 MG 2 TABLET ,90, % 22.91% Y FLUCONAZOLE J2A4 ZOCON 150 MG TABLET 1 ZOCON FDC LTD. 150 MG 1 TABLET ,04,14, % 22.91% Y FLUCONAZOLE J2A4 SURFAZ O 150 MG TABLET 1 SURFAZ O FRANCO INDIAN PHARMACEUTICALS PVT LTD 150 MG 1 TABLET ,52, % 0.57% N FLUCONAZOLE J2A4 FUZOL 150 MG TABLET 1 FUZOL FRANKLIN LABORATORIES (INDIA) PVT. LTD. 150 MG 1 TABLET ,05, % 0.02% N FLUCONAZOLE J2A4 FLUCAN 150 MG TABLET 1 FLUCAN GALPHA LABORATORIES LTD 150 MG 1 TABLET ,61, % 0.02% N FLUCONAZOLE J2A4 FZHH 150 MG TABLET 1 FZHH HEGDE & HEGDE 150 MG 1 TABLET ,01, % 1.35% Y FLUCONAZOLE J2A4 GOCAN 150 MG TABLET 1 GOCAN HETERO HEALTHCARE LTD 150 MG 1 TABLET ,08,81, % 3.07% Y FLUCONAZOLE J2A4 HILZOL 150 MG TABLET 1 HILZOL HINDUSTAN LATEX LTD. 150 MG 1 TABLET ,80, % 0.07% N FLUCONAZOLE J2A4 FCONAZ 150 MG TABLET 1 FCONAZ IATROS PHARMACEUTICALS PVT. LTD. 150 MG 1 TABLET ,79, % 0.04% N FLUCONAZOLE J2A4 FUNGAL F 150 MG TABLET 1 FUNGAL F INGA LABORATORIES PVT. LTD. 150 MG 1 TABLET ,71, % 0.10% N FLUCONAZOLE J2A4 FCN 150 MG TABLET 1 FCN INTAS PHARMACEUTICALS LTD 150 MG 1 TABLET ,99, % 0.47% N FLUCONAZOLE J2A4 FLUTAS 150 MG TABLET 1 FLUTAS INTAS PHARMACEUTICALS LTD 150 MG 1 TABLET ,57, % 0.47% N FLUCONAZOLE J2A4 TRIBEN F 150 MG TABLET 1 TRIBEN F JENBURKT PHARMACEUTICALS LTD 150 MG 1 TABLET ,53, % 0.41% N Levelwise O% ) Price Unit Price Unit

4 S. Unique Composition as प क ववरण क पन 39 FLUCONAZOLE J2A4 NAZOLE 150 MG TABLET 1 NAZOLE KAPTAB 150 MG 1 TABLET ,27, % 0.06% N FLUCONAZOLE J2A4 NTFUNG 150 MG TABLET 1 NTFUNG KIVI LABS LTD 150 MG 1 TABLET ,92, % 0.06% N FLUCONAZOLE J2A4 FLUMET (LEEFORD) 150 MG TABLET 1 FLUMET (LEEFORD) LEEFORD HEALTHCARE 150 MG 1 TABLET ,87, % 0.03% N FLUCONAZOLE J2A4 BTC 150 MG TABLET 1 BTC LINCOLN PHARMACEUTICALS LTD 150 MG 1 TABLET ,70, % 0.17% N FLUCONAZOLE J2A4 ANTIF 150 MG TABLET 1 ANTIF LITAKA PHARMACEUTICALS LTD 150 MG 1 TABLET , % 0.01% N FLUCONAZOLE J2A4 FLUCALUP 150 MG TABLET 1 FLUCALUP LUPIN LTD 150 MG 1 TABLET , % 0.01% N FLUCONAZOLE J2A4 FLUCOFIT 150 MG TABLET 1 FLUCOFIT MANEESH PHARMACEUTICALS LTD 150 MG 1 TABLET ,01, % 0.01% N FLUCONAZOLE J2A4 NUFORCE 150 MG TABLET 1 NUFORCE MANKIND PHARMACEUTICALS LTD. 150 MG 1 TABLET ,59,12, % 18.53% Y FLUCONAZOLE J2A4 MCSTAT 150 MG TABLET 1 MCSTAT MCASTRO PHARMA 150 MG 1 TABLET ,69, % 0.03% N FLUCONAZOLE J2A4 FAZE 150 MG TABLET 1 FAZE MEGHA HEALTHCARE 150 MG 1 TABLET ,93, % 0.25% N FLUCONAZOLE J2A4 FLUTICAN 150 MG TABLET 1 FLUTICAN MONICHEM HEALTHCARE PVT LTD 150 MG 1 TABLET ,34, % 0.02% N FLUCONAZOLE J2A4 FLUOL 150 MG TABLET 10 FLUOL MORACEAE PHARMACEUTICALS PVT LTD 150 MG 10 TABLET ,59, % 0.04% N FLUCONAZOLE J2A4 FUTIZA 150 MG TABLET 1 FUTIZA MOREPEN LABORATORIES LIMITED 150 MG 1 TABLET , % 0.01% N FLUCONAZOLE J2A4 FLUCESS 150 MG TABLET 1 FLUCESS NOVARTIS INDIA LTD 150 MG 1 TABLET , % 0.01% N FLUCONAZOLE J2A4 NUFLUCON 150 MG TABLET 1 NUFLUCON NULIFE PHARMACEUTICALS 150 MG 1 TABLET , % 0.01% N FLUCONAZOLE J2A4 ULTICAN 150 MG TABLET 1 ULTICAN OCHOA LABORATIORIES LTD 150 MG 1 TABLET , % 0.01% N FLUCONAZOLE J2A4 FLUDON (PANZER) 150 MG TABLET 1 FLUDON (PANZER) PANZER PHARMACEUTICALS PVT LTD 150 MG 1 TABLET ,31, % 0.20% N FLUCONAZOLE J2A4 FLORET 150 MG TABLET 1 FLORET PASTEUR LABORATORIES PVT. LTD. 150 MG 1 TABLET , % 0.01% N FLUCONAZOLE J2A4 ODCAN 150 MG TABLET 1 ODCAN PRISM LIFESCIENCE 150 MG 1 TABLET ,38, % 0.04% N FLUCONAZOLE J2A4 MYCONORM F 150 MG TABLET 1 MYCONORM F PSYCHOTROPICS INDIA LTD 150 MG 1 TABLET , % 0.01% N FLUCONAZOLE J2A4 ODICON 150 MG TABLET 15 ODICON RAPROSS PHARMACEUTICALS PVT LTD 150 MG 15 TABLET ,30, % 0.18% N FLUCONAZOLE J2A4 ODICON 150 MG TABLET 1 ODICON RAPROSS PHARMACEUTICALS PVT LTD 150 MG 1 TABLET ,94, % 0.18% N FLUCONAZOLE J2A4 FLUSYST 150 MG TABLET 1 FLUSYST RELIANCE FORMULATION PVT LTD 150 MG 1 TABLET ,30, % 0.02% N FLUCONAZOLE J2A4 SANCAN 150 MG TABLET 10 SANCAN SANJIVINI BIOTECH PRIVATE LIMITED 150 MG 10 TABLET , % 0.01% N FLUCONAZOLE J2A4 ZEFUN 150 MG TABLET 2 ZEFUN SH PHARMACEUTICALS LTD 150 MG 2 TABLET ,48, % 0.40% N FLUCONAZOLE J2A4 SOLCAN 150 MG TABLET 1 SOLCAN SOLDERMA PHARMACEUTICALS PVT. LTD 150 MG 1 TABLET ,35, % 0.08% N FLUCONAZOLE J2A4 STAFLU 150 MG TABLET 2 STAFLU STAUNCH PHARMACEUTICALS 150 MG 2 TABLET ,20, % 0.06% N FLUCONAZOLE J2A4 STEFAZOL 150 MG TABLET 1 STEFAZOL SUN PHARMA (RANBAXY LABORATORIES LTD) 150 MG 1 TABLET , % 0.01% N FLUCONAZOLE J2A4 AF 150 MG TABLET DT 1 AF SYSTOPIC LABORATORIES LTD-MEM 150 MG 1 TABLET DT ,25,14, % 9.20% Y FLUCONAZOLE J2A4 FA (THRIFT) 150 MG TABLET 1 FA (THRIFT) THRIFT PHARMACEUTICALS 150 MG 1 TABLET ,01, % 0.03% N FLUCONAZOLE J2A4 FLUTEC 150 MG TABLET 1 FLUTEC TRIPADA BIOTEC PVT LTD 150 MG 1 TABLET ,09, % 0.02% N FLUCONAZOLE J2A4 CANZIKA 150 MG TABLET 1 CANZIKA TROIKAA PHARMACEUTICALS LTD 150 MG 1 TABLET ,71, % 0.05% N FLUCONAZOLE J2A4 FOLE 150 MG TABLET 1 FOLE UNISON PHARMACEUTICALS 150 MG 1 TABLET ,36,47, % 3.48% Y FLUCONAZOLE J2A4 CANEX 150 MG TABLET 1 CANEX VANCE & HEALTH PHARMACEUTICALS LTD 150 MG 1 TABLET ,62, % 0.24% N FLUCONAZOLE J2A4 VILZOLE 150 MG TABLET 1 VILZOLE VILCO LABORATORIES PVT. LTD 150 MG 1 TABLET , % 0.01% N FLUCONAZOLE J2A4 ONECAN 150 MG TABLET 1 ONECAN WALLACE PHARMACEUTICALS LTD. 150 MG 1 TABLET ,91,01, % 16.05% Y FLUCONAZOLE J2A4 CANAWAR 150 MG TABLET 1 CANAWAR WINDLAS BIOTECH LTD 150 MG 1 TABLET ,25, % 0.02% N FLUCONAZOLE J2A4 FUNAZ 150 MG TABLET 1 FUNAZ WOCKHARDT LTD 150 MG 1 TABLET ,61, % 0.13% N FLUCONAZOLE J2A4 TUCANOZOL 150 MG TABLET 1 TUCANOZOL ZUVENTUS HEALTHCARE LTD 150 MG 1 TABLET , % 0.05% N FLUCONAZOLE J2A4 FLUNOVA 150 MG TABLET 1 FLUNOVA ZUVENTUS HEALTHCARE LTD 150 MG 1 TABLET ,66, % 0.05% N FLUCONAZOLE J2A4 FLUGEE 150 MG TABLET 1 FLUGEE ZYDUS CADILA 150 MG 1 TABLET , % 12.75% Y FLUCONAZOLE J2A4 FLUMED 150 MG TABLET 1 FLUMED ZYDUS CADILA 150 MG 1 TABLET , % 12.75% Y FLUCONAZOLE J2A4 FUSYS 150 MG TABLET 1 FUSYS ZYDUS CADILA 150 MG 1 TABLET ,65,18, % 12.75% Y Levelwise O% ) Price Unit Price Unit

5 S. Unique ड प स ओ 2013 क प र 4 क तहत, अग त 2015 क आ कड़ क आध रत, म य क स गणन Number of Companies consisting of Market Share of 1% & Above CETIRIZINE 10MG Tablet Per Tablet Sum of value considered for price calculation (in Lakhs) Sum of PTR unit considered for price calculation Number of s considered 22 Average PTR 1.35 Add : 16% Retailer Margin 0.22 Ceiling Price (without local taxes) 1.57 % Reduction with compared to Highest Price 21.51% WPI Reduction wef % 0.04 Final Ceiling Price (without local taxes) 1.53 Composition as प क ववरण Minimum Price 0.19 S.O. 619(E) dated Maximum Price 1.72 Ceiling Price as Per Tablet Average of all considered 1.35 Derived PTR 1.72 Ceiling Price 1.57 क पन TOTAL 83,37,67, % Levelwise O% ) CETIRIZINE R6A3 CETAG 10 MG TABLET 10 CETAG AGRON REMEDIES PVT. LTD. 10 MG 10 TABLET , % 0.01% N CETIRIZINE R6A3 CETRAL O 10 MG TABLET 10 CETRAL O ALEMBIC LTD 10 MG 10 TABLET , % 0.06% N CETIRIZINE R6A3 CETRAL 10 MG TABLET 10 CETRAL ALEMBIC LTD 10 MG 10 TABLET ,12, % 0.06% N CETIRIZINE R6A3 CETIRIZ 10 MG TABLET 10 CETIRIZ ALKEM LABORATORIES LTD. 10 MG 10 TABLET ,90,63, % 7.08% Y CETIRIZINE R6A3 ANZIN 10 MG TABLET 10 ANZIN AN PHARMACEUTICALS PVT.LTD. 10 MG 10 TABLET ,69, % 0.02% N CETIRIZINE R6A3 DORIZ 10 MG TABLET 10 DORIZ ARTEL LABORATORIES 10 MG 10 TABLET , % 0.01% N CETIRIZINE R6A3 INCID L 10 MG TABLET 10 INCID L BAYER PHARMACEUTICALS PVT. LTD. 10 MG 10 TABLET ,33,86, % 2.80% Y CETIRIZINE R6A3 TANCET 10 MG TABLET 10 TANCET BIOCHEM PHARMACEUTICAL INDS 10 MG 10 TABLET ,90, % 0.06% N CETIRIZINE R6A3 CETRIZINE (BLUE CROSS) 10 MG TABLET 10 CETRIZINE (BLUE CROSS) BLUE CROSS LABORATORIES LTD 10 MG 10 TABLET ,01, % 0.04% N CETIRIZINE R6A3 EKON 10 MG TABLET 10 EKON BLUE CROSS LABORATORIES LTD 10 MG 10 TABLET ,14, % 0.04% N CETIRIZINE R6A3 CETCIP 10 MG TABLET 10 CETCIP CIPLA LTD. 10 MG 10 TABLET ,16, % 7.68% Y CETIRIZINE R6A3 OKACET 10 MG TABLET 10 OKACET CIPLA LTD. 10 MG 10 TABLET ,67, % 7.68% Y CETIRIZINE R6A3 ALERID 10 MG TABLET 10 ALERID CIPLA LTD. 10 MG 10 TABLET ,48,72, % 7.68% Y CETIRIZINE R6A3 ZYRTEC OD 10 MG TABLET 10 ZYRTEC DR. REDDYS LABORATORIES LTD 10 MG 10 TABLET , % 3.75% Y CETIRIZINE R6A3 CETRINE 10 MG TABLET 10 CETRINE DR. REDDYS LABORATORIES LTD 10 MG 10 TABLET ,67, % 3.75% Y CETIRIZINE R6A3 ZYRTEC 10 MG TABLET 10 ZYRTEC DR. REDDYS LABORATORIES LTD 10 MG 10 TABLET ,05,19, % 3.75% Y CETIRIZINE R6A3 ALCE 10 MG TABLET 10 ALCE FRANKLIN LABORATORIES (INDIA) PVT. LTD. 10 MG 10 TABLET ,60, % 0.06% N CETIRIZINE R6A3 CETZINE 10 MG TABLET 100 CETZINE GLAXOSMITHKLINE PHARMACEUTICALS LTD. 10 MG 100 TABLET ,32, % 28.42% Y CETIRIZINE R6A3 CETZINE 10 MG TABLET 10 CETZINE GLAXOSMITHKLINE PHARMACEUTICALS LTD. 10 MG 10 TABLET ,54,93, % 28.42% Y CETIRIZINE R6A3 FORMICET 10 MG TABLET 10 FORMICET GROUP PHARMACEUTICALS LTD. 10 MG 10 TABLET ,64, % 0.07% N CETIRIZINE R6A3 TRIZ 10 MG TABLET 10 TRIZ INDOCO REMEDIES LTD 10 MG 10 TABLET ,87,21, % 4.64% Y CETIRIZINE R6A3 CETIN 10 MG TABLET 10 CETIN INDSWIFT LABORATORIES LTD. 10 MG 10 TABLET ,06, % 0.12% N CETIRIZINE R6A3 ALLERZINE 10 MG TABLET 10 ALLERZINE JENBURKT PHARMACEUTICALS LTD 10 MG 10 TABLET ,03, % 0.13% N CETIRIZINE R6A3 ANTIZED 10 MG TABLET 10 ANTIZED KENTRECK LABS PVT. LTD. 10 MG 10 TABLET ,94, % 0.02% N CETIRIZINE R6A3 KIVICET 10 MG TABLET 10 KIVICET KIVI LABS LTD 10 MG 10 TABLET ,58, % 0.07% N CETIRIZINE R6A3 SATRIN 10 MG TABLET 10 SATRIN LINCOLN PHARMACEUTICALS LTD 10 MG 10 TABLET ,72, % 0.07% N CETIRIZINE R6A3 CZ-3 10 MG TABLET 10 CZ-3 LUPIN LTD 10 MG 10 TABLET ,81,62, % 6.98% Y CETIRIZINE R6A3 RINITRIN 10 MG TABLET 10 RINITRIN MANEESH PHARMACEUTICALS LTD 10 MG 10 TABLET ,59, % 0.03% N CETIRIZINE R6A3 COPE 10 MG TABLET DT 10 COPE MANKIND PHARMACEUTICALS LTD. 10 MG 10 TABLET DT ,03, % 1.60% Y CETIRIZINE R6A3 COPE-MD 10 MG TABLET MD 10 COPE-MD MANKIND PHARMACEUTICALS LTD. 10 MG 10 TABLET MD ,20, % 1.60% Y CETIRIZINE R6A3 COPE 10 MG TABLET 10 COPE MANKIND PHARMACEUTICALS LTD. 10 MG 10 TABLET ,07,87, % 1.60% Y CETIRIZINE R6A3 ODACET 10 MG TABLET 10 ODACET MAPRA LABORATORIES PVT. LTD 10 MG 10 TABLET ,00, % 0.18% N CETIRIZINE R6A3 NOVAHIST (MICRO) 10 MG TABLET 10 NOVAHIST (MICRO) MICRO LABS LTD 10 MG 10 TABLET , % 2.52% Y CETIRIZINE R6A3 HICET 10 MG TABLET 10 HICET MICRO LABS LTD 10 MG 10 TABLET ,94, % 2.52% Y CETIRIZINE R6A3 ALLERCET 10 MG TABLET 10 ALLERCET MICRO LABS LTD 10 MG 10 TABLET ,28,53, % 2.52% Y CETIRIZINE R6A3 CETRINAT 10 MG TABLET 10 CETRINAT NATCO PHARMA LTD 10 MG 10 TABLET ,32, % 0.02% N CETIRIZINE R6A3 ALERGID 10 MG TABLET 10 ALERGID ORTIN 10 MG 10 TABLET , % 0.01% N CETIRIZINE R6A3 CTZ (PSYCHOTROPICS) 10 MG TABLET 10 CTZ (PSYCHOTROPICS) PSYCHOTROPICS INDIA LTD 10 MG 10 TABLET ,97, % 0.02% N CETIRIZINE R6A3 SUHIT 10 MG TABLET 10 SUHIT RAMOSE LABORATORIES PVT. LTD. 10 MG 10 TABLET , % 0.04% N CETIRIZINE R6A3 SUHIT COLD 10 MG TABLET 10 SUHIT COLD RAMOSE LABORATORIES PVT. LTD. 10 MG 10 TABLET ,11, % 0.04% N CETIRIZINE R6A3 CETTOP 10 MG TABLET 10 CETTOP RELIANCE FORMULATION PVT LTD 10 MG 10 TABLET , % 0.01% N CETIRIZINE R6A3 AVIL NU 10 MG TABLET 10 AVIL NU SANOFI INDIA LTD. 10 MG 10 TABLET ,78,92, % 10.54% Y Price Unit Price Unit

6 S. Unique Composition as प क ववरण क पन 43 CETIRIZINE R6A3 ALERTAC 10 MG TABLET 10 ALERTAC SEAGULL LABS(I) LTD 10 MG 10 TABLET ,15, % 0.12% N CETIRIZINE R6A3 ALDAY 10 MG TABLET 10 ALDAY SH PHARMACEUTICALS LTD 10 MG 10 TABLET ,12,27, % 15.74% Y CETIRIZINE R6A3 CEDAY (HIQUEM LAB) 10 MG TABLET 10 CEDAY (HIQUEM LAB) SHRINIVAS GUJARAT LABORATORIES PVT LTD 10 MG 10 TABLET ,42, % 0.20% N CETIRIZINE R6A3 ACET 10 MG TABLET 10 ACET SHRINIVAS GUJARAT LABORATORIES PVT LTD 10 MG 10 TABLET ,23, % 0.20% N CETIRIZINE R6A3 STANHIST 10 MG TABLET 10 STANHIST SUN PHARMA (RANBAXY LABORATORIES LTD) 10 MG 10 TABLET ,55, % 0.03% N CETIRIZINE R6A3 CETRIZET 10 MG TABLET 10 CETRIZET SUN PHARMA LTD. 10 MG 10 TABLET ,99, % 0.28% N CETIRIZINE R6A3 CTCOM 10 MG TABLET 10 CTCOM SYNCOM FORMULATIONS (I) LIMITED 10 MG 10 TABLET ,42, % 0.15% N CETIRIZINE R6A3 SIZON 10 MG TABLET 10 SIZON SYSTOPIC LABORATORIES LTD-MEM 10 MG 10 TABLET ,34, % 0.45% N CETIRIZINE R6A3 CET (TARGOF) 10 MG TABLET 10 CET (TARGOF) TARGOF PURE DRUGS TD. 10 MG 10 TABLET , % 0.01% N CETIRIZINE R6A3 CETRAMAC 10 MG TABLET 10 CETRAMAC TORQUE PHARMACEUTICALS PVT LTD 10 MG 10 TABLET ,93, % 0.12% N CETIRIZINE R6A3 ZYNCET 10 MG TABLET 10 ZYNCET UNICHEM LABORATORIES LTD 10 MG 10 TABLET ,45,94, % 4.15% Y CETIRIZINE R6A3 DIO-1 10 MG TABLET 10 DIO-1 UNISON PHARMACEUTICALS 10 MG 10 TABLET ,30,27, % 1.56% Y CETIRIZINE R6A3 CETRIZINE (WOCKHARDT) 10 MG TABLET 10 CETRIZINE (WOCKHARDT) WOCKHARDT LTD 10 MG 10 TABLET ,28, % 0.05% N CETIRIZINE R6A3 SETRIDE 10 MG TABLET 1000 SETRIDE WOCKHARDT LTD 10 MG 1000 TABLET ,05, % 0.05% N CETIRIZINE R6A3 SETRIDE 10 MG TABLET 10 SETRIDE WOCKHARDT LTD 10 MG 10 TABLET ,97, % 0.05% N CETIRIZINE R6A3 CETLERGY 10 MG TABLET 10 CETLERGY ZUVENTUS HEALTHCARE LTD 10 MG 10 TABLET ,84, % 0.05% N CETIRIZINE R6A3 CETICAD 10 MG TABLET 10 CETICAD ZYDUS CADILA 10 MG 10 TABLET ,91, % 0.02% N 0.17 Levelwise O% ) Price Unit Price Unit

7 ड प स ओ 2013 क प र 4 क तहत, अग त 2015 क आ कड़ क आध रत, म य क स गणन Number of Companies consisting of Market Share of 1% & Above 9 Sum of value considered for price calculation (in Lakhs) 4, DICLOFENAC 50 MG Tablet Per Tablet Sum of PTR unit considered for price calculation Number of s considered 11 S. No. Unique No. as Composition as प क ववरण Average PTR 1.57 Add : 16% Retailer Margin 0.25 Ceiling Price (without local taxes) 1.82 % Reduction with compared to Highest Price 15.14% WPI Reduction wef % 0.05 Final Ceiling Price (without local taxes) 1.77 Minimum Price 1.19 S.O. 619(E) dated Maximum Price 1.85 Ceiling Price as Per Tablet Average of all considered 1.57 Derived PTR 1.85 Ceiling Price 1.82 क पन TOTAL 46,14,71, % Y=Yes N=No Price Unit Price Unit DICLOFENAC M1A12 TOPAC 50 MG TABLET 10 TOPAC ABBOTT HEALTHCARE PVT. LTD 50 MG 10 TABLET , % N DICLOFENAC M1A12 ZOBID D 50 MG TABLET 10 ZOBID D ABBOTT HEALTHCARE PVT. LTD 50 MG 10 TABLET ,39,38, % Y DICLOFENAC M1A12 VOVO 50 MG TABLET 10 VOVO ALEMBIC LTD 50 MG 10 TABLET , % N DICLOFENAC M1A12 DICLOTAL 50 MG TABLET DT 10 DICLOTAL BLUE CROSS LABORATORIES LTD 50 MG 10 TABLET DT ,58, % Y DICLOFENAC M1A12 REACTIN 50 MG TABLET DT 10 REACTIN CIPLA LTD. 50 MG 10 TABLET DT ,14, % N DICLOFENAC M1A12 REACTIN 50 MG TABLET 10 REACTIN CIPLA LTD. 50 MG 10 TABLET ,24, % N DICLOFENAC M1A12 DENSAID QA 50 MG TABLET 10 DENSAID QA DELVIN FORMULATIONS PRIVATE LTD 50 MG 10 TABLET ,09, % N DICLOFENAC M1A12 SUPANAC 50 MG TABLET 10 SUPANAC DR. REDDYS LABORATORIES LTD 50 MG 10 TABLET , % N DICLOFENAC M1A12 ELDOFEN 50 MG TABLET 10 ELDOFEN ELDER PHARMACEUTICALS LTD 50 MG 10 TABLET , % N DICLOFENAC M1A12 ORONAC 50 MG TABLET 10 ORONAC EMBIOTIC LAB 50 MG 10 TABLET , % N DICLOFENAC M1A12 DICLORAN 50 MG TABLET 10 DICLORAN JB CHEMICALS 50 MG 10 TABLET ,46, % Y DICLOFENAC M1A12 TOPAC (KIVI) 50 MG TABLET 10 TOPAC (KIVI) KIVI LABS LTD 50 MG 10 TABLET , % N DICLOFENAC M1A12 LARFEN 50 MG TABLET 10 LARFEN LARK LABORATORIES LTD 50 MG 10 TABLET , % N DICLOFENAC M1A12 VIVIAN 50 MG TABLET 10 VIVIAN LINCOLN PHARMACEUTICALS LTD 50 MG 10 TABLET , % N DICLOFENAC M1A12 DEFENAC 50 MG TABLET 10 DEFENAC LUPIN LTD 50 MG 10 TABLET , % N DICLOFENAC M1A12 DICLONAC 50 MG TABLET 10 DICLONAC LUPIN LTD 50 MG 10 TABLET ,47, % N DICLOFENAC M1A12 DILONA 50 MG TABLET 10 DILONA MAPRA LABORATORIES PVT. LTD 50 MG 10 TABLET ,48, % N DICLOFENAC M1A12 DILONA D 50 MG TABLET 10 DILONA D MAPRA LABORATORIES PVT. LTD 50 MG 10 TABLET ,64, % N DICLOFENAC M1A12 DILONA FORTE 50 MG TABLET 10 DILONA MAPRA LABORATORIES PVT. LTD 50 MG 10 TABLET ,08,51, % Y DICLOFENAC M1A12 DIVON 50 MG TABLET 10 DIVON MICRO LABS LTD 50 MG 10 TABLET ,53, % Y DICLOFENAC M1A12 NEUROFLAM 50 MG TABLET 10 NEUROFLAM NOVARTIS INDIA LTD 50 MG 10 TABLET ,37, % N DICLOFENAC M1A12 VOVERAN 50 MG TABLET DT 10 VOVERAN NOVARTIS INDIA LTD 50 MG 10 TABLET DT ,85, % N DICLOFENAC M1A12 VOLTAFLAM 50 MG TABLET 10 VOLTAFLAM NOVARTIS INDIA LTD 50 MG 10 TABLET ,31,91, % Y DICLOFENAC M1A12 VOVERAN D 50 MG TABLET DT 10 VOVERAN NOVARTIS INDIA LTD 50 MG 10 TABLET DT ,60,10, % Y DICLOFENAC M1A12 VOVERAN 50 MG TABLET 15 VOVERAN NOVARTIS INDIA LTD 50 MG 15 TABLET ,51,09, % Y DICLOFENAC M1A12 DILOFEN 50 MG TABLET 10 DILOFEN P &B LABORATORIES PVT LTD 50 MG 10 TABLET ,14, % N DICLOFENAC M1A12 DK (SOICO) 50 MG TABLET 10 DK (SOICO) SOICO PHARMACEUTICALS LTD 50 MG 10 TABLET ,30, % N DICLOFENAC M1A12 FENAK 50 MG TABLET 10 FENAK SUN PHARMA (RANBAXY LAB) 50 MG 10 TABLET ,23, % N DICLOFENAC M1A12 VOLINI 50 MG TABLET 10 VOLINI SUN PHARMA (RANBAXY LAB) 50 MG 10 TABLET ,34, % N DICLOFENAC M1A12 DICLONIJ DT 50 MG TABLET 10 DICLONIJ SUNIJ PHARMA PVT LTD 50 MG 10 TABLET , % N DICLOFENAC M1A12 NAC 50 MG TABLET 10 NAC SYSTOPIC LABORATORIES LTD-MEM 50 MG 10 TABLET ,10, % Y DICLOFENAC M1A12 ROLOD K 50 MG TABLET 10 ROLOD K TIDAL LABORATORIES PVT LTD 50 MG 10 TABLET , % N DICLOFENAC M1A12 DYNAPAR EC 50 MG TABLET 10 DYNAPAR TROIKAA PHARMACEUTICALS LTD 50 MG 10 TABLET ,60,70, % Y DICLOFENAC M1A12 DAN 50 MG TABLET 10 DAN UNISON PHARMACEUTICALS 50 MG 10 TABLET ,65, % N DICLOFENAC M1A12 SOLUDOL 50 MG TABLET 10 SOLUDOL WIN-MEDICARE PVT. LTD. 50 MG 10 TABLET ,80, % N DICLOFENAC M1A12 ACTIVA 50 MG TABLET 10 ACTIVA ZYDUS CADILA 50 MG 10 TABLET ,00, % N DICLOFENAC M1A12 INAC 50 MG TABLET 4 INAC ZYDUS CADILA 50 MG 4 TABLET ,66, % N DICLOFENAC M1A12 JONAC 50 MG TABLET 10 JONAC ZYDUS CADILA 50 MG 10 TABLET ,30, % N DICLOFENAC M1A12 INAC 50 MG TABLET 10 INAC ZYDUS CADILA 50 MG 10 TABLET ,38,00, % Y

8 ड प स ओ 2013 क प र 4 क तहत, अगत 2015 क आ कड़ क आध रत, म य क स गणन Number of Companies consisting of Market Share of 1% & Above 4 Sum of value considered for price calculation (in Lakhs) 3, TRIHEXYPHENIDYL 2 MG Tablet Per Tablet Sum of PTR unit considered for price calculation 7.03 Number of s considered 7 Average PTR 1.00 Add : 16% Retailer Margin 0.16 Ceiling Price (without local taxes) 1.16 % Reduction with compared to Highest Price 22.48% WPI Reduction wef % 0.03 Final Ceiling Price (without local taxes) 1.13 S. No. Unique No. as Composition as Minimum Price 0.45 S.O. 619(E) dated Maximum Price 1.29 Ceiling Price as Per Tablet Average of all considered 1.00 Derived PTR 1.30 Ceiling Price 1.16 TOTAL 34,88,54, % TRIHEXYPHENIDYL N4A10 TRIXYL 2 MG TABLET 10 TRIXYL A.N.PHARMACIA 2 MG 10 TABLET , % 0.03% N TRIHEXYPHENIDYL N4A10 PARKINTA 2 MG TABLET 10 PARKINTA ARINNA LIFESCIENCES PVT. LTD 2 MG 10 TABLET ,57, % 0.07% N TRIHEXYPHENIDYL N4A10 DYSKINIL 2 MG TABLET 10 DYSKINIL CRESCENT FORMULATIONS PVT. LTD. 2 MG 10 TABLET ,66, % 0.42% N TRIHEXYPHENIDYL N4A10 PARNIL 2 MG TABLET 10 PARNIL D.D PHARMACEUTICALS 2 MG 10 TABLET , % 0.01% N TRIHEXYPHENIDYL N4A10 TRIHEXY 2 MG TABLET 10 TRIHEXY GUJARAT TERCE LABORATORIES LTD 2 MG 10 TABLET , % 0.01% N TRIHEXYPHENIDYL N4A10 BEXOL 2 MG TABLET DT 50 BEXOL INTAS PHARMACEUTICALS LTD 2 MG 50 TABLET DT ,97, % 9.79% Y TRIHEXYPHENIDYL N4A10 BEXOL 2 MG TABLET DT 100 BEXOL INTAS PHARMACEUTICALS LTD 2 MG 100 TABLET DT ,12, % 9.79% Y TRIHEXYPHENIDYL N4A10 BEXOL 2 MG TABLET 10 BEXOL INTAS PHARMACEUTICALS LTD 2 MG 10 TABLET ,48,23, % 9.79% Y TRIHEXYPHENIDYL N4A10 HEKSI 2 MG TABLET 10 HEKSI KIVI LABS LTD 2 MG 10 TABLET ,60, % 0.39% N TRIHEXYPHENIDYL N4A10 LAHEXY 2 MG TABLET 10 LAHEXY LA PHARMACEUTICALS 2 MG 10 TABLET ,35, % 0.07% N TRIHEXYPHENIDYL N4A10 ECITANE 2 MG TABLET 10 ECITANE LINUX LABORATORIES 2 MG 10 TABLET ,32, % 0.12% N TRIHEXYPHENIDYL N4A10 TRYAL(MANKIND) 2 MG TABLET 10 TRYAL(MANKIND) MANKIND PHARMACEUTICALS LTD. 2 MG 10 TABLET ,43, % 0.18% N TRIHEXYPHENIDYL N4A10 PARKIN 2 MG TABLET 10 PARKIN MICRO LABS LTD 2 MG 10 TABLET ,30,19, % 12.33% Y TRIHEXYPHENIDYL N4A10 MOVAHEXY 2 MG TABLET MD 10 MOVAHEXY MOVA PHARMACEUTICALS PVT LTD 2 MG 10 TABLET MD ,32, % 0.24% N TRIHEXYPHENIDYL N4A10 MANOHEXY 2 MG TABLET 10 MANOHEXY ORCHID CHEMICALS & PHARMACEUTICALS LTD 2 MG 10 TABLET , % 0.01% N TRIHEXYPHENIDYL N4A10 RINI 2 MG TABLET 10 RINI OXFORD PHARMACEUTICALS PVT LTD 2 MG 10 TABLET ,50, % 0.07% N TRIHEXYPHENIDYL N4A10 PACITANE 2 MG TABLET 70 PACITANE PFIZER LTD 2 MG 70 TABLET ,61, % 72.51% Y TRIHEXYPHENIDYL N4A10 PACITANE 2 MG TABLET PACITANE PFIZER LTD 2 MG 30 TABLET ,50,91, % 72.51% Y TRIHEXYPHENIDYL N4A10 PARALES 2 MG TABLET 10 PARALES PSYCORMEDIES 2 MG 10 TABLET ,61, % 0.05% N TRIHEXYPHENIDYL N4A10 RELIHEXY 2 MG TABLET 10 RELIHEXY RELIANCE FORMULATION PVT LTD 2 MG 10 TABLET ,49, % 0.16% N TRIHEXYPHENIDYL N4A10 PTEMPT 2 MG TABLET 10 PTEMPT S.P PHARMA 2 MG 10 TABLET ,23, % 0.06% N TRIHEXYPHENIDYL N4A10 TREMNIL 2 MG TABLET 10 TREMNIL SHINE PHARMACEUTICALS LTD 2 MG 10 TABLET ,06, % 0.83% N TRIHEXYPHENIDYL N4A10 TRYHP 2 MG TABLET 10 TRYHP SIGMUND PROMEDICA 2 MG 10 TABLET , % 0.02% N TRIHEXYPHENIDYL N4A10 PARKITANE 2 MG TABLET 10 PARKITANE SUN PHARMA LABORATORIES LTD. 2 MG 10 TABLET ,06, % 0.09% N TRIHEXYPHENIDYL N4A10 TRIPHEN 2 MG TABLET 10 TRIPHEN SUN PHARMA LABORATORIES LTD. 2 MG 10 TABLET ,06, % 0.98% N TRIHEXYPHENIDYL N4A10 HEXYLENT 2 MG TABLET 10 HEXYLENT TALENT HEALTHCARE 2 MG 10 TABLET ,46, % 1.30% Y TRIHEXYPHENIDYL N4A10 TRI EX 2 MG TABLET 10 TRI EX TAS MED (INDIA) PRIVATE LTD. 2 MG 10 TABLET ,17, % 0.26% N 1.11 Brandwis e O% ) Y=Yes N=No Price Unit Price Unit

9 ड प स ओ 2013 क प र 4 क तहत, अगत 2015 क आ कड़ क आध रत, म य क स गणन Number of Companies consisting of Market Share of 1% & Above 5 Sum of value considered for price calculation (in Lakhs) 3, PROPRANOLOL 40 MG Tablet Per Tablet Sum of PTR unit considered for price calculation Number of s considered 7 Average PTR 2.29 Add : 16% Retailer Margin 0.37 Ceiling Price (without local taxes) 2.66 % Reduction with compared to Highest Price 5.76% WPI Reduction wef % 0.07 Final Ceiling Price (without local taxes) 2.59 S. Unique Composition as Minimum Price 2.15 S.O. 619(E) dated Maximum Price 2.43 Ceiling Price as Per Tablet Average of all considered 2.29 Derived PTR 2.43 Ceiling Price 2.66 TOTAL 32,98,38, % PROPRANOLOL C7A37 PILOL 40 MG TABLET 10 PILOL A.N.PHARMACIA 40 MG 10 TABLET , % 0.01% N PROPRANOLOL C7A37 INDERAL 40 MG TABLET 10 INDERAL ABBOTT INDIA LTD. 40 MG 10 TABLET ,92,24, % 33.11% Y PROPRANOLOL C7A37 NORTEN 40 MG TABLET 10 NORTEN BARODA PHARMA PVT. LTD 40 MG 10 TABLET ,65, % 0.93% N PROPRANOLOL C7A37 CIPLAR LA 40 MG TABLET 10 CIPLAR CIPLA LTD. 40 MG 10 TABLET ,22,38, % 53.24% Y PROPRANOLOL C7A37 CIPLAR 40 MG TABLET 15 CIPLAR CIPLA LTD. 40 MG 15 TABLET ,33,66, % 53.24% Y PROPRANOLOL C7A37 PROLOL 40 MG TABLET 10 PROLOL CRESCENT FORMULATIONS PVT. LTD. 40 MG 10 TABLET ,04, % 0.06% N PROPRANOLOL C7A37 PROVANOL 40 MG TABLET 10 PROVANOL INTAS PHARMACEUTICALS LTD 40 MG 10 TABLET ,97, % 8.68% Y PROPRANOLOL C7A37 PROVANOL SR 40 MG TABLET 10 PROVANOL INTAS PHARMACEUTICALS LTD 40 MG 10 TABLET ,72,43, % 8.68% Y PROPRANOLOL C7A37 CARDIMOL 40 MG TABLET SR 10 CARDIMOL MANKIND PHARMACEUTICALS LTD. 40 MG 10 TABLET SR ,33, % 0.19% N PROPRANOLOL C7A37 TENPOSE SR 40 MG TABLET 10 TENPOSE MANKIND PHARMACEUTICALS LTD. 40 MG 10 TABLET ,29, % 1.13% Y PROPRANOLOL C7A37 MOVALOL 40 MG TABLET 10 MOVALOL MOVA PHARMACEUTICALS PVT LTD 40 MG 10 TABLET , % 0.09% N PROPRANOLOL C7A37 MOVALOL 40 MG TABLET SR 10 MOVALOL MOVA PHARMACEUTICALS PVT LTD 40 MG 10 TABLET SR ,20, % 0.09% N PROPRANOLOL C7A37 ARKAPROP 40 MG TABLET 10 ARKAPROP RKG PHARMA 40 MG 10 TABLET , % 0.02% N PROPRANOLOL C7A37 PONOL 40 MG TABLET 10 PONOL SHINE PHARMACEUTICALS LTD 40 MG 10 TABLET ,45, % 0.21% N PROPRANOLOL C7A37 PONOL 40 MG TABLET TR 10 PONOL SHINE PHARMACEUTICALS LTD 40 MG 10 TABLET TR ,53, % 0.21% N PROPRANOLOL C7A37 SIGNOLOL TR 40 MG TABLET 10 SIGNOLOL SIGMUND PROMEDICA 40 MG 10 TABLET ,26, % 0.13% N PROPRANOLOL C7A37 MIBETA 40 MG TABLET SR 10 MIBETA TAS MED (INDIA) PRIVATE LTD. 40 MG 10 TABLET SR ,44, % 1.38% Y PROPRANOLOL C7A37 THEOLAR 40 MG TABLET 10 THEOLAR THEO PHARMA PVT. LTD. 40 MG 10 TABLET , % 0.06% N PROPRANOLOL C7A37 THEOLAR SR 40 MG TABLET 10 THEOLAR THEO PHARMA PVT. LTD. 40 MG 10 TABLET ,50, % 0.06% N PROPRANOLOL C7A37 BELOC TR 40 MG TABLET 10 BELOC TRIPADA HEALTHCARE PVT LTD 40 MG 10 TABLET ,09, % 0.07% N PROPRANOLOL C7A37 BELOC 40 MG TABLET 10 BELOC TRIPADA HEALTHCARE PVT LTD 40 MG 10 TABLET ,19, % 0.07% N PROPRANOLOL C7A37 TRILOL SR 40 MG TABLET 10 TRILOL TRITON HEALTH CARE PVT LTD 40 MG 10 TABLET ,76, % 0.11% N PROPRANOLOL C7A37 NIGRAIN TR 40 MG TABLET 10 NIGRAIN UNICHEM LABORATORIES LTD 40 MG 10 TABLET ,06, % 0.58% N 2.13 Brandwis e O% ) Y=Yes N=No Price Unit Price Unit

10 ड प स ओ 2013 क प र 4 क तहत, अगत 2015 क आ कड़क आध रत, म य कस गणन Number of Companies consisting of Market Share of 1% & Above 8 Sum of value considered for price calculation (in Lakhs) IINIB 400 MG Tablet Per Tablet Sum of PTR unit considered for price calculation Number of s considered 13 Average PTR Add : 16% Retailer Margin Ceiling Price (without local taxes) % Reduction with compared to Highest Price 23.14% WPI Reduction wef % 5.94 Final Ceiling Price (without local taxes) S. Unique Composition as Minimum Price S.O. 619(E) dated Maximum Price Ceiling Price as Per Tablet Average of all considered Derived PTR Ceiling Price TOTAL 34,00,89, % IINIB MESYLATE L1X16 ALTANIB 400 MG TABLET 10 ALTANIB ALKEM LABORATORIES LTD. 400 MG 10 TABLET 2, ,25, % 2.45% Y IINIB MESYLATE L1X16 I 400 MG TABLET 10 I BIOCHEM PHARMACEUTICAL INDS 400 MG 10 TABLET 1, ,05,96, % 11.94% Y IINIB MESYLATE L1X16 CADINIB 400 MG TABLET 10 CADINIB CADILA PHARMACEUTICALS LTD 400 MG 10 TABLET 2, ,96, % 0.47% N Levelwise O% ) 4 IINIB MESYLATE L1X16 CELONIB 400 MG TABLET 10 CELONIB CELON LABS 400 MG 10 TABLET 1, ,25, % 0.92% N IINIB MESYLATE L1X16 IIB 400 MG TABLET 10 IIB CIPLA LTD. 400 MG 10 TABLET 2, ,80, % 2.79% Y IINIB MESYLATE L1X16 LEVIN(DRL) 400 MG TABLET 10 LEVIN(DRL) DR. REDDYS LABORATORIES LTD 400 MG 10 TABLET 2, ,19,58, % 9.40% Y IINIB MESYLATE L1X16 MITINAB 400 MG TABLET 6 MITINAB GLENMARK PHARMACEUTICALS LTD. 400 MG 6 TABLET 1, ,94, % 0.53% N IINIB MESYLATE L1X16 IERO 400 MG TABLET 10 IERO HETERO HEALTHCARE LTD 400 MG 10 TABLET 1, ,27, % 0.48% N IINIB MESYLATE L1X16 IMANIB 400 MG TABLET 10 IMANIB INTAS PHARMACEUTICALS LTD 400 MG 10 TABLET 1, ,44,15, % 28.53% Y IINIB MESYLATE L1X16 IMANIB 400 MG TABLET 30 IMANIB INTAS PHARMACEUTICALS LTD 400 MG 30 TABLET 5, ,26,05, % 28.53% Y IINIB MESYLATE L1X16 LUPINIB 400 MG TABLET 10 LUPINIB LUPIN LTD 400 MG 10 TABLET 1, ,03,65, % 3.05% Y IINIB MESYLATE L1X16 VEENAT 400 MG TABLET 30 VEENAT NATCO PHARMA LTD 400 MG 30 TABLET 6, ,45, % 32.06% Y IINIB MESYLATE L1X16 VEENAT 400 MG TABLET 10 VEENAT NATCO PHARMA LTD 400 MG 10 TABLET 2, ,08,01, % 32.06% Y IINIB MESYLATE L1X16 GLIVAC 400 MG TABLET GLIVAC NOVARTIS INDIA LTD 400 MG 10 TABLET 2, ,55, % 0.60% N IINIB MESYLATE L1X16 ZEALATA 400 MG TABLET 10 ZEALATA SUN PHARMA (RANBAXY LAB) 400 MG 10 TABLET 2, ,22, % 6.79% Y IINIB MESYLATE L1X16 IMALEK 400 MG TABLET 10 IMALEK SUN PHARMA (RANBAXY LAB) 400 MG 10 TABLET 1, ,23, % 6.79% Y IINIB MESYLATE L1X16 IMALEK 400 MG TABLET 6 IMALEK SUN PHARMA (RANBAXY LAB) 400 MG 6 TABLET 1, ,41, % 6.79% Y IINIB MESYLATE L1X16 IINIB 400 MG TABLET 10 IINIB SUN PHARMA (RANBAXY LAB) 400 MG 10 TABLET 1, ,43,09, % 6.79% Y Price Unit Price Unit

11 ड प स ओ 2013 क प र 4 क तहत, अगत 2015 क आ कड़ क आध रत, म य क स गणन Number of Companies consisting of Market Share of 1% & Above AMOXYCILLIN 250 MG Capsule Per Capsule Sum of value considered for price calculation (in Lakhs) Sum of PTR unit considered for price calculation Number of s considered 12 Average PTR 1.82 Add : 16% Retailer Margin 0.29 Ceiling Price (without local taxes) 2.11 % Reduction with compared to Highest Price 30.53% WPI Reduction wef % 0.06 Final Ceiling Price (without local taxes) 2.05 Minimum Price 0.60 S.O. 619(E) dated Maximum Price 2.62 Ceiling Price as Per Capsule Average of all considered 1.82 Derived PTR 2.62 Ceiling Price 2.11 S. Unique Composition as TOTAL 28,49,64, % AMOXYCILLIN J1C1 RONEMOX 250 MG CAPSULE 10 RONEMOX ABBOTT HEALTHCARE PVT. LTD 250 MG 10 CAPSULE ,12, % 0.81% N AMOXYCILLIN J1C1 SYMOXYL 250 MG CAPSULE 6 SYMOXYL ABBOTT HEALTHCARE PVT. LTD 250 MG 6 CAPSULE ,13, % 0.81% N AMOXYCILLIN J1C1 AMUROL NX 250 MG CAPSULE 10 AMUROL NX ALEMBIC LTD 250 MG 10 CAPSULE , % 0.03% N AMOXYCILLIN J1C1 ALMOX 250 MG CAPSULE 15 ALMOX ALKEM LABORATORIES LTD. 250 MG 15 CAPSULE , % 4.56% Y AMOXYCILLIN J1C1 AMOXY 250 MG CAPSULE 10 AMOXY ALKEM LABORATORIES LTD. 250 MG 10 CAPSULE , % 4.56% Y AMOXYCILLIN J1C1 MOXIKEM 250 MG CAPSULE 10 MOXIKEM ALKEM LABORATORIES LTD. 250 MG 10 CAPSULE ,88, % 4.56% Y AMOXYCILLIN J1C1 ALMOX 250 MG CAPSULE 10 ALMOX ALKEM LABORATORIES LTD. 250 MG 10 CAPSULE ,25,44, % 4.56% Y AMOXYCILLIN J1C1 PENOM 250 MG CAPSULE 10 PENOM APOSTLE REMEDIES 250 MG 10 CAPSULE , % 0.03% N AMOXYCILLIN J1C1 BLUMOX 250 MG CAPSULE 10 BLUMOX BLUE CROSS LABORATORIES LTD 250 MG 10 CAPSULE ,32, % 0.12% N AMOXYCILLIN J1C1 MOKCAN 250 MG CAPSULE 10 MOKCAN CADILA PHARMACEUTICALS LTD 250 MG 10 CAPSULE , % 0.03% N AMOXYCILLIN J1C1 CIPMOX 250 MG CAPSULE 10 CIPMOX CIPLA LTD. 250 MG 10 CAPSULE ,55, % 29.82% Y AMOXYCILLIN J1C1 NOVAMOX 250 MG CAPSULE 15 NOVAMOX CIPLA LTD. 250 MG 15 CAPSULE ,20,20, % 29.82% Y AMOXYCILLIN J1C1 TOXI 250 MG CAPSULE 10 TOXI FRANKLIN LABORATORIES (INDIA) PVT. LTD. 250 MG 10 CAPSULE ,90, % 0.10% N AMOXYCILLIN J1C1 MOXXIL 250 MG CAPSULE 10 MOXXIL GUJARAT TERCE LABORATORIES LTD 250 MG 10 CAPSULE ,07, % 0.07% N AMOXYCILLIN J1C1 MOXICA 250 MG CAPSULE 10 MOXICA INDICA LABORATORIES PVT. LTD. 250 MG 10 CAPSULE ,52, % 0.05% N AMOXYCILLIN J1C1 MOXIPAL 250 MG CAPSULE 10 MOXIPAL JAGSONPAL PHARMACEUTICALS LTD 250 MG 10 CAPSULE ,51, % 1.14% Y AMOXYCILLIN J1C1 LABMOX 250 MG CAPSULE 10 LABMOX LABORATE PHARMACEUTICAL LTD 250 MG 10 CAPSULE , % 0.03% N AMOXYCILLIN J1C1 LUPIMOX 250 MG CAPSULE 10 LUPIMOX LUPIN LTD 250 MG 10 CAPSULE , % 0.07% N AMOXYCILLIN J1C1 LUPIMOX 250 MG CAPSULE 15 LUPIMOX LUPIN LTD 250 MG 15 CAPSULE ,56, % 0.07% N AMOXYCILLIN J1C1 TRIMOX 250 MG CAPSULE 10 TRIMOX MAPRA LABORATORIES PVT. LTD 250 MG 10 CAPSULE ,25, % 0.08% N AMOXYCILLIN J1C1 OCTAMOX 250 MG CAPSULE 10 OCTAMOX MEDISPAN LTD 250 MG 10 CAPSULE ,84, % 0.36% N AMOXYCILLIN J1C1 OCTAMOX 250 MG CAPSULE 15 OCTAMOX MEDISPAN LTD 250 MG 15 CAPSULE ,51, % 0.36% N AMOXYCILLIN J1C1 PULMOXYL 250 MG CAPSULE 10 PULMOXYL MICRO LABS LTD 250 MG 10 CAPSULE ,11, % 6.27% Y AMOXYCILLIN J1C1 EROX 250 MG CAPSULE 10 EROX MICRO LABS LTD 250 MG 10 CAPSULE ,41,49, % 6.27% Y AMOXYCILLIN J1C1 MORMOX 250 MG CAPSULE 10 MORMOX MOREPEN LABORATORIES LIMITED 250 MG 10 CAPSULE , % 0.01% N AMOXYCILLIN J1C1 OSPAMOX 250 MG CAPSULE 10 OSPAMOX NOVARTIS INDIA LTD 250 MG 10 CAPSULE ,26, % 0.04% N AMOXYCILLIN J1C1 WYMOX 250 MG CAPSULE 15 WYMOX PFIZER LTD 250 MG 15 CAPSULE ,11,65, % 10.94% Y AMOXYCILLIN J1C1 Q MOX(QUE PHARMA) 250 MG CAPSULE 10 Q MOX(QUE PHARMA) QUE PHARMA PVT. LTD. 250 MG 10 CAPSULE , % 0.02% N AMOXYCILLIN J1C1 MOXRAY 250 MG CAPSULE 10 MOXRAY SHREYA LIFE SCIENCES PVT. LTD 250 MG 10 CAPSULE , % 0.02% N AMOXYCILLIN J1C1 ROSCILLIN AMX 250 MG CAPSULE 10 ROSCILLIN AMX SUN PHARMA (RANBAXY LAB.) 250 MG 10 CAPSULE ,59, % 44.92% Y AMOXYCILLIN J1C1 MOX 250 MG CAPSULE 15 MOX SUN PHARMA (RANBAXY LAB.) 250 MG 15 CAPSULE ,78,43, % 44.92% Y AMOXYCILLIN J1C1 AMOX 250 MG CAPSULE 10 AMOX SYNCHEM LAB 250 MG 10 CAPSULE , % 0.21% N AMOXYCILLIN J1C1 AMOX(SYNCHEM LAB) 250 MG CAPSULE 10 AMOX(SYNCHEM LAB) SYNCHEM LAB 250 MG 10 CAPSULE ,39, % 0.21% N AMOXYCILLIN J1C1 AMOXYCILLIN (TORQUE) 250 MG CAPSULE 10 AMOXYCILLIN (TORQUE) TORQUE PHARMACEUTICALS PVT LTD 250 MG 10 CAPSULE , % 0.03% N AMOXYCILLIN J1C1 MERIMOX 250 MG CAPSULE 10 MERIMOX WOCKHARDT LTD 250 MG 10 CAPSULE ,13, % 0.04% N AMOXYCILLIN J1C1 MOXYZEN 250 MG CAPSULE 10 MOXYZEN ZENITH HEALTHCARE LTD 250 MG 10 CAPSULE , % 0.01% N AMOXYCILLIN J1C1 ATMOX 250 MG CAPSULE 10 ATMOX ZOTA PHARMACEUTICALS 250 MG 10 CAPSULE ,58, % 0.06% N AMOXYCILLIN J1C1 AMOXIL 250 MG CAPSULE 10 AMOXIL ZYDUS CADILA 250 MG 10 CAPSULE ,53, % 0.12% N 1.60 Levelwise O% ) Price Unit Price Unit

Minimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33

Minimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33 Computataion of Retail Price based on Jan.-2016 Data under Para 4 of DPCO 2013 Cholecalciferol 800 IU Drops of M/s Raptakos, Brett & Co.Ltd. Number of Companies cosisting of Market Share of 1% & Above

More information

Minimumum Price (Rs.) 6.93 Maximum Price (Rs.) Average of all considered (Rs.) 8.97 Retail Price (Rs.) 10.41

Minimumum Price (Rs.) 6.93 Maximum Price (Rs.) Average of all considered (Rs.) 8.97 Retail Price (Rs.) 10.41 S. No. Computataion of Retail Price based on May, 2016 Data under Para 4 of DPCO 2013 ASPIRIN 75mg + ROSUVASTATIN 10mg + CLOPIDOGREL 75mg Tablet of M/s Safetab Life Science/M/s Intas Pharmaceuticals Ltd.

More information

TOTAL MAT 1,52,81, % Unit PTR (Rs.) MAT (Rs.) SKU wise MAT % प क व रण Pack Description छ प BRAND. क पन Company. S. No. Unique No.

TOTAL MAT 1,52,81, % Unit PTR (Rs.) MAT (Rs.) SKU wise MAT % प क व रण Pack Description छ प BRAND. क पन Company. S. No. Unique No. Number of Companies consisting of Market Share of 1% & Above 2 3.1 Adrenaline Injection 1 mg/ml Per ml Sum of MAT value considered for price calculation (in Lakhs) 152.69 Sum of PTR per unit considered

More information

Minimum Price (Rs.) Maximum Price (Rs.) Average of all considered (Rs.) Ceiling Price (Rs.)

Minimum Price (Rs.) Maximum Price (Rs.) Average of all considered (Rs.) Ceiling Price (Rs.) Computation of Ceiling based on Aug-2015 Data under Para 4 of DPCO 2013 8.1.34 Temozolomide 250mg Tabs Per Tablet Number of Companies consisting of Market Share of 1% & Above 2 Sum of MAT value considered

More information

RESULTS AND DISCUSSION

RESULTS AND DISCUSSION RESULTS AND DISCUSSION 203 4.1 General Introduction: The researcher has collected both the primary and secondary data. The primary data is collected by direct interaction by using formal questionnaire

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 14.03.2016 IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. TABLETS (INDIA) LIMITED 5973 APPROVAL 2. TABLETS (INDIA) LIMITED 5974 APPROVAL 3. CLARIS OTSUKA PRIVATE LIMITED 7373 APPROVAL

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 15.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1 M/S NATCO PHARMA LIMITED HYDERABAD MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. GENETIX BIOTECH ASIA PVT. LTD. 22073 APPROVAL

More information

ORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet

ORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority

More information

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20)

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20) (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical

More information

TODAY LETTER DATED

TODAY LETTER DATED TODAY LETTER DATED 26.06.2018 GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. RESEARCH ASSOCIATES INDIA PVT.. 18670 PA APPROVAL LETTER LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 25.04.2017 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ALEMBIC PHARMACEUTICALS 2. M/S. ALEMBIC PHARMACEUTICALS 3. M/S. ALEMBIC PHARMACEUTICALS 4. M/S. EMCURE PHARMACEUTICALS

More information

New Delhi, the 18 th December, 2017 ORDER

New Delhi, the 18 th December, 2017 ORDER (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 01.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S TYCHE INDUSTRIES LTD., ANDHRA PRADESH, INDIA IMPORT S. NAME OF APPLICANT DIARY TYPE OF 1. PIRAMAL ENTERPRISES LTD. 25471 APPROVAL

More information

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of s National Pricing Authority ORDER New

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 21.06.2016 LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. GLOBAL PHARMA HEALTHCARE PVT. LTD., THIRUPORUR 27509 APPROVAL BIOLOGICAL DIVISION NAME OF COMPANY DY.NO. STATUS

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 05.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE OF DOCUMENT 1. M/S. ARRIGO INTERNATIONAL,INDORE 2 M/S. EUROLIFE HEALTHCARE PVT. LTD. HARIDWAR NEW DRUG S. NAME OF APPLICANT DIARY TYPE

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON LETTERS FOR ISSUE ON 27.12.2017 LVP DIVISION S. NO. COMPANY NAME FTS NO. /Diary No. STATUS 01 M/s. Akums Drugs & Pharmaceuticals, Haridwar 02 M/s. Unique Pharmaceutical Laboratories,Guj. (License No.4)

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 04.12.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. VIRCHOW BIOTECH PVT LTD - QUERY 2. M/S. MSN LABORATORIES PVT - CT-NOC & BE NOC LTD (3) 3. M/S. NATCO PHARMA LTD. - BE-NOC

More information

NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order,

NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, What s New 12.06.2018 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, 2013 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations

More information

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin Clopidogrel Tablet

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin Clopidogrel Tablet (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 11.04.2017 BIOLOGICAL DIVISION NAME OF COMPANY DY. NO. STATUS M/S ZUVENTUS HEALTHCARE LTD 6981 APPROVAL M/S TECHINVENTION LIFE SCIENCES 1208 CLARIFICATION M/S CADILA PHARMACEUTICALS LTD

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 14.12.2015 LVP DIVISION S. COMPANY NAME FTS /DIARY STATUS 01 M/S. AXA PARENTERALS LTD., ROORKEE 60262 APPROVAL 02 M/S. UNIJULES LIFE SCIENCES LTD., NAGPUR 61147 APPROVAL 03 M/S. INNVOL MEDICAL

More information

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA 1 Agio Pharmaceuticals Limited 15/31/2013-EP(Engg) dt:21.11.2013 7,98,217.00 2 Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg) dt:21.11.2013 15,10,268.00 3 Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg)

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 03.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S LUPIN TARAPUR, MAHARASHTRA & WC 2. M/S JPN PHARMA PVT. PALGHAR, MAHARASHTRA WC 3. M/S OPTIMUS DRUGS A.P. WC VACCINE DIVISION S.

More information

Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013

Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Sl. No. F.No. Name of the Company/ Formulation Date of receipt of application

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 17.05.2016 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH MUMBAI-400709 2. M/S. ACCUTEST RESEARCH MUMBAI-400709 3. M/S. ACCUTEST RESEARCH MUMBAI-400709

More information

Dataset : PharmaTrac MAT MAY PharmaTrac Overview MAY 18

Dataset : PharmaTrac MAT MAY PharmaTrac Overview MAY 18 PharmaTrac Overview MAY 18 8434 8956 9655 10422 8112 8917 9549 8258 8921 9406 8668 9630 9381 8662 8373 8999 9013 9796 10413 8742 9315 10050 8458 9180 8601 9092 9767 8364 9145 10583 10173 10387 10217 10476

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 19.06.2015 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI-400 709 2. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT.,

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 17.07.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY TYPE OF NO. 1. M/S. CIREX PHARMACEUTICALS LTD - QUERY 2. M/S. LUPIN LIMITED - ADDITIONAL SITES REGISTRATION S.NO. NAME OF APPLICANT DIARY

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 04.10.2017 MEDICAL DEVICE DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14608 QUERY 2. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14609 QUERY 3. DR. ULHAS

More information

BRIC DIABETES DRUGS MARKET

BRIC DIABETES DRUGS MARKET BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a

More information

REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38

REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38 CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED

More information

Global Aspergillosis Drugs Market Professional Survey Report 2016

Global Aspergillosis Drugs Market Professional Survey Report 2016 Report Information More information from: https://www.wiseguyreports.com/reports/526011 Global Aspergillosis Drugs Market Professional Survey Report 2016 Report / Search Code: WGR526011 Publish Date: 24

More information

What s New

What s New What s New 23.12.2016 NPPA has fixed/revised ceiling prices of 55 scheduled formulations of Schedule-I under Drugs ( Control) Amendment Order,2016 and Retail of 29 formulations under DPCO, 2013 in related

More information

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA Disbursement of MDA Claims to Individual Exporters during (-11) 1 JPN Pharma API China 80,000.00 2 Unique Biotech Limited Bio May 3-6, 80,000.00 3 Titan Biotech Limited Cphi Japan 21st to 23rd April 80,000.00

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 29.11.2016 COSMETICS DIVISION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. WELLA INDIA PVT. LTD., MUMBAI 29233, 29524 & 28513 APPROVAL 2. M/S. PROCTER & GAMBLE HOME PRODUCTS PVT. LTD.,

More information

Information for Vermont Prescribers of Prescription Drugs Long Form

Information for Vermont Prescribers of Prescription Drugs Long Form Information for Vermont Prescribers of Prescription Drugs Long Form Pylera (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride) Capsules The prices listed below are Average Wholesale

More information

Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets

Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets The prices listed below are Average Wholesale Prices ( AWP ) as established and made available to the public

More information

Case 1:14-cv LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023

Case 1:14-cv LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023 Case 1:14-cv-00121-LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FOREST LABO RA TORIES, INC., FOREST LABO RA TORIES HOLDINGS,

More information

File no./drug Name Name of firm/ Institute Recommendations. New Drugs Division

File no./drug Name Name of firm/ Institute Recommendations. New Drugs Division Recommendations: I approve the minutes of 52 nd SEC (Oncology & hematology) held on 13.04.2017 at CDSCO HQ New Delhi and recommended the following: Agenda 1 12-63/16-DC Ferric Pyrophosphate citrate solution

More information

A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database

A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database Contract Research Organization / Terzetto Pharma Metrics NIVETHA CHELLAPATHY

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/7.5/0281 PHARMACARE LIMITED

More information

Anti Diabetic. BE Reference product. Diamicron Gliclazide MR Tablets 60 mg (Servier, France) HCl XR Tablets 500 mg (BMS, US)

Anti Diabetic. BE Reference product. Diamicron Gliclazide MR Tablets 60 mg (Servier, France) HCl XR Tablets 500 mg (BMS, US) Anti Diabetic Gliclazide 30/60 mg ER Tablets Diamicron Gliclazide MR Tablets 60 mg (Servier, France) Tajikistan (Under registration), Vietnam, Uzbekistan US (Filed 2010) US (2013) India (2006), Vietnam

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs ZOLOFT (sertraline hydrochloride) tablets, for oral use This list does not imply that the products on this chart are interchangeable or have the

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs ARTHROTEC (diclofenac sodium/misoprostol) tablets This list does not imply that the products on this chart are interchangeable or have the same

More information

Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules

Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules The prices listed below are Average Wholesale Prices ( AWP ) as established and made

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs ARTHROTEC (diclofenac sodium/misoprostol) tablets This list does not imply that the products on this chart are interchangeable or have the same

More information

Medicines availability short-term supply issues Last updated 01/05/18

Medicines availability short-term supply issues Last updated 01/05/18 Short-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability within the next three months. This list is

More information

List of Companies suspected for Non Compliance of ceiling prices based on Pharmatrac Column 10 shows the ceiling price fixed by NPPA for the pack

List of Companies suspected for Non Compliance of ceiling prices based on Pharmatrac Column 10 shows the ceiling price fixed by NPPA for the pack Column 11 shows the Maximum Retail Price of the formulation admissible as per the NPPA ceiling price fixation Sl No SKU SUBGROUP COMPANY List of Companies suspected for Non Compliance of ceiling prices

More information

10 th SEC- (Reproductive & Urology)meetingheld on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi PROGRAMME SCHEDULE

10 th SEC- (Reproductive & Urology)meetingheld on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi PROGRAMME SCHEDULE 10 th SEC- (Reproductive & Urology)meetingheld on 16-01-2015 at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi 110 002 PROGRAMME SCHEDULE Recommendation:- The 10 th SEC (Reproductive and Urology) meeting

More information

SAY "NO" TO ELDER ABUSE 4 th National Elder Abuse Conference BHUTANESE COMMUNITY ड प र सनक ल ग न ई भन न

SAY NO TO ELDER ABUSE 4 th National Elder Abuse Conference BHUTANESE COMMUNITY ड प र सनक ल ग न ई भन न SAY "NO" TO ELDER ABUSE 4 th National Elder Abuse Conference BHUTANESE COMMUNITY ड प र सनक ल ग न ई भन न City of Salisbury approach Salisbury is a multicultural council area We have a large CHSP program

More information

M/s. Hetero Labs Ltd.

M/s. Hetero Labs Ltd. :- The 1 st SEC (Gastroenterology&Hepatology) meeting deliberated the proposals on 06.01.2017 and recommended the following:- Agenda New Drugs Division Proposal 1 12-54/16-DC Sofosbuvir and Velpatasvir

More information

Public Policy

Public Policy Public Policy www.nipunalambayan.com Public policy - Policy made by government www.nipunindia.in 1 1 Directive Principles of state policy Part - 4 Article 36-51 Ireland Constitution www.nipunindia.in 2

More information

4.1. Hindi Transliteration

4.1. Hindi Transliteration 1 Hindi Typing Help Type as you type hindi in english and give a space, it will auto convert it to hindi. For examle if you type itihaas and give space it will convert it to. If the converted word is not

More information

Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on and recommended the following:-

Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on and recommended the following:- Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on 05.11.2014 and recommended the following:- Agend a No. File No. 1. File No.: 12-75/13-DC Afatinib film coated tablet

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 27.08.2015 NEW DRUG S. NAME OF APPLICANT DIARY TYPE OF 1. M/S. INTAS PHARMACEUTICALS LIMITED - CT NOC (2) 2. M/S. PFIZER LIMITED - QUERY 3. M/S. MSN LABORATORIES - ADDITIONAL SITE 4. M/S.

More information

No. Karaikal / Gr.A /1(17)/Contract / 2016 Date:

No. Karaikal / Gr.A /1(17)/Contract / 2016 Date: जव हरल ल स न तक त तर आय र व ज ञ न श क ष एव अन स ध न स स थ न JAWAHARLAL INSTITUTE OF POST GRADUATE MEDICAL EDUCATION & RESEARCH (स व स य एव पररव र कल य ण म त र लय, भ रत सरक र क अध न र ष ट र य महत व क स

More information

DLB 1

DLB 1 DLB 1 2 3 4 5 The NCI will act as an apex body for the network of the SCIs and TCCCs and shall develop and mentor Cancer related activities. Apart from treatment, the centre s main focus will be translational

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

TOTAL MAT 1,50,05, % Unit PTR (Rs.) MAT (Rs.) SKU wise Qualify. Size

TOTAL MAT 1,50,05, % Unit PTR (Rs.) MAT (Rs.) SKU wise Qualify. Size Computataion of Retail Price based on Feb., 2014 Data under Para 4 of DPCO 2013 Hyoscine Butyl Bromide 10mg + Paracetamol 325 mg of M/s Kemwell Biopharma Pvt. Ltd & M/s Boehringer Ingelheim Pvt. Ltd Number

More information

CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...

CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW... CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST

More information

Access to Quality Medicines and Health Products in Rajasthan

Access to Quality Medicines and Health Products in Rajasthan Review Article imedpub Journals http://www.imedpub.com Journal of Healthcare Communications ISSN 2472-1654 DOI: 10.4172/2472-1654.100082 Access to Quality Medicines and Health Products in Rajasthan Nirmal

More information

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Product Number API Test product Dose/ mg Manufacturer Country of manufacture Country

More information

Detailed cost of vaccination/ Immunization in India (Birth to 10 years of age)

Detailed cost of vaccination/ Immunization in India (Birth to 10 years of age) Detailed cost of vaccination/ Immunization in India (Birth to 10 years of age) Glossary: IPV= Injectable Polio vaccine OPV= Oral polio vaccine (these are oral drops, which is also given in "Pulse Polio

More information

BOTANICAL AND PLANT-DERIVED DRUGS: GLOBAL MARKETS

BOTANICAL AND PLANT-DERIVED DRUGS: GLOBAL MARKETS BOTANICAL AND PLANT-DERIVED DRUGS: GLOBAL MARKETS BIO022G August 2015 Kim Lawson Project Analyst ISBN: 1-62296-134-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA

More information

म हल ह थक यर स त और र ग य एवम उपय

म हल ह थक यर स त और र ग य एवम उपय म हल ह थक यर स त और र ग य एवम उपय पर स ग ठ Seminar On Women Healthcare Obstetrics and Gynecological Instruments and Appliances आय जक च क स उपकरण एवम अ पत ल य जन वभ ग भ रत य म नक य र Organized By Medical

More information

Mukand Lal Public School, Sarojini Colony, Ynr. Class:- IV( )

Mukand Lal Public School, Sarojini Colony, Ynr. Class:- IV( ) Mukand Lal Public School, Sarojini Colony, Ynr E-mail ID:-mlps2008ynr@rediffmail.com Website: www.mlpschool.edu.in GUIDELINES FOR HOLIDAY HOMEWORK:- Class:- IV( 2018-19) 1.) Grand Parents must help children

More information

Vol. II, Issue I January S&A PHARMA NEWSLETTER Vol. I, Issue I

Vol. II, Issue I January S&A PHARMA NEWSLETTER Vol. I, Issue I Vol. II, Issue I January 2018 S&A PHARMA NEWSLETTER Vol. I, Issue I EDITORIAL Manoj K. Singh Founding Partner The globalization of Healthcare offers a certain degree of exposure of foreign services, ideas,

More information

List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities)

List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities) Edition: Version 11-19th of July 2018 List of A & B Products List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities) As from the version

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

Creating Lasting Value

Creating Lasting Value Creating Lasting Value Investor Presentation Sept 2017 NSE:SUNPHARMA BSE:524715 Bloomberg:SUNP IN Reuters:SUN.BO WWW.SUNPHARMA.COM Disclaimer Except for the historical information contained herein, statements

More information

PROVISIONAL RATE LIST FOR NIT 120 (Pharma)

PROVISIONAL RATE LIST FOR NIT 120 (Pharma) all 1 120003 Acenocoumarol/Nicoumalone Tablet 2 mg 10 x 10 15,000 L1 CIRON DRUGS AND PHARMACEUTICALS PVT LTD 259.0004 259.0004 L2 ABBOTT HEALTHCARE PRIVATE LIMITED 386.66 405.993 2 Adrenochrome Monosemicarbazone

More information

3. Dr.Rajutitus Chacko, Prof. & Head, Dept. of Medical Oncology, CMC, Vellore.

3. Dr.Rajutitus Chacko, Prof. & Head, Dept. of Medical Oncology, CMC, Vellore. MINUTES OF THE 6 th MEETING OF TECHNICAL COMMITTEE HELD ON 25-07-2013 UNDER CHAIRMANSHIP OF DGHS FOR SUPERVISING CLINICAL TRIALS ON NEW CHEMICAL ENTITIES IN THE LIGHT OF DIRECTIONS OF THE HON BLE SUPREME

More information

Creating Lasting Value

Creating Lasting Value Creating Lasting Value Investor Presentation April 2017 NSE:SUNPHARMA BSE:524715 Bloomberg:SUNP IN Reuters:SUN.BO WWW.SUNPHARMA.COM Disclaimer Except for the historical information contained herein, statements

More information

1.स न न न ह त ह ए भ चश म ऱ क क प ट न क य कह ज त थ? 2.म र तय ऩर सरक ड क चश म क य उम म द जग त ह? 6.ग वऩय द र उद ध क भ ग य न कहन म क य व य ग य र नहहत ह?

1.स न न न ह त ह ए भ चश म ऱ क क प ट न क य कह ज त थ? 2.म र तय ऩर सरक ड क चश म क य उम म द जग त ह? 6.ग वऩय द र उद ध क भ ग य न कहन म क य व य ग य र नहहत ह? क द र य व द य ऱय ओ.एन.ज.स. श स गर, असम ग र ष म क ह त ग हक यय सत र 2018-2019 क X व षय हहन द 1.स न न न ह त ह ए भ चश म ऱ क क प ट न क य कह ज त थ? 2.म र तय ऩर सरक ड क चश म क य उम म द जग त ह? 3 ककन आध र ऩर ब

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 06/17.1.6/07 AFRIVET LOGISTICS

More information

Creating Lasting Value

Creating Lasting Value Creating Lasting Value Investor Presentation May 2018 NSE:SUNPHARMA BSE:524715 Bloomberg:SUNP IN Reuters:SUN.BO WWW.SUNPHARMA.COM Disclaimer Except for the historical information contained herein, statements

More information

Creating Lasting Value

Creating Lasting Value Creating Lasting Value Investor Presentation February 2017 NSE:SUNPHARMA BSE:524715 Bloomberg:SUNP IN Reuters:SUN.BO WWW.SUNPHARMA.COM Disclaimer Except for the historical information contained herein,

More information

HTET Answer Key by

HTET Answer Key by HTET 2013-14 Answer Key by www.educationbhaskar.com ANSWER KEYS ENGLISHPart IIILanguage IIEnglish,Child depvlopement & Hindi.. Q. 61.Choose the correct passive construction Even work and patience can solve

More information

Statement showing the Item wise BFC Approved list for TNo.2/TSMSIDC/Medicines/ , Dt

Statement showing the Item wise BFC Approved list for TNo.2/TSMSIDC/Medicines/ , Dt Statement showing the Item wise BFC Approved list for TNo.2/TSMSIDC/Medicines/2016 18, Dt.24.05.2016 Sl. No Code Group Item Name Firm Name Unit L1 Rate 1 2193 EML Aceclofenac 100mg Tab Deepin Pharmaceuticals

More information

र व न श एव अन स ध न स स थ न JAWAHARLAL INSTITUTE OF POST GRADUATE MEDICAL EDUCATION & RESEARCH

र व न श एव अन स ध न स स थ न JAWAHARLAL INSTITUTE OF POST GRADUATE MEDICAL EDUCATION & RESEARCH जव हरऱ ऱ र व न श एव अन स ध न स स थ न JAWAHARLAL INSTITUTE OF POST GRADUATE MEDICAL EDUCATION & RESEARCH (स व स य एव ऩररव र कल य ण म त र ऱय, भ रत सरक र क अध न र ष ट र य महत व क स स थ न) (An Institution

More information

STAFF SELECTION COMMISSION

STAFF SELECTION COMMISSION STAFF SELECTION COMMISSION Instruction to the Candidates for Stenography Test for Stenographer Grade D & Grade C & Departmental Examinations (On Computer) 1. The Commission will provide the Computer and

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE

More information

Edmund Healthcare Pvt. Ltd.

Edmund Healthcare Pvt. Ltd. +91-8048410921 Edmund Healthcare Pvt. Ltd. https://www.edmundhealthcare.in/ Our firm is ranked as the leading Trader and Supplier of a wide array of Pharmaceutical Injection, Pharmaceutical Tablets, Pharmaceutical

More information

Recommendations of thesec (Dermatology & Allergy) made in its 23 rd meeting held on at CDSCO HQ New Delhi: New Drugs Division

Recommendations of thesec (Dermatology & Allergy) made in its 23 rd meeting held on at CDSCO HQ New Delhi: New Drugs Division Recommetions of thesec (Dermatology & Allergy) made in its 23 rd meeting held on 11.05.2017 at CDSCO HQ New Delhi: File /Drug Name Recommetions New Drugs Division 1 12-28/15-DC (Pt-B) Apremilast 10/20/30

More information

Free Trial Future Generics Database

Free Trial Future Generics Database API Atazanavir Structure O 2 C N H O H N OH N NH O N H N CO2 Brand REYATAZ (BMS : World) Indication Antiviral Originator Ciba-Geigy (Novartis) Developer / Licensee BMS Comments Atazanavir is an azapeptide

More information

TABLE 7 ADVANTAGES AND DISADVANTAGES OF TOXOID VACCINES SUBUNIT VACCINES Applications of Subunit Vaccines TABLE 8 APPLICATIONS OF

TABLE 7 ADVANTAGES AND DISADVANTAGES OF TOXOID VACCINES SUBUNIT VACCINES Applications of Subunit Vaccines TABLE 8 APPLICATIONS OF CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED

More information

Creating Lasting Value

Creating Lasting Value Creating Lasting Value Investor Presentation February 2018 NSE:SUNPHARMA BSE:524715 Bloomberg:SUNP IN Reuters:SUN.BO WWW.SUNPHARMA.COM Disclaimer Except for the historical information contained herein,

More information

Creating Lasting Value

Creating Lasting Value Creating Lasting Value Investor Presentation November 2018 NSE:SUNPHARMA BSE:524715 Bloomberg:SUNP IN Reuters:SUN.BO WWW.SUNPHARMA.COM Disclaimer Except for the historical information contained herein,

More information

Creating Lasting Value

Creating Lasting Value Creating Lasting Value Investor Presentation November 2018 NSE:SUNPHARMA BSE:524715 Bloomberg:SUNP IN Reuters:SUN.BO WWW.SUNPHARMA.COM Disclaimer Except for the historical information contained herein,

More information

Total ADMINISTRATIVE BLOCK, JIPMER

Total ADMINISTRATIVE BLOCK, JIPMER जव हरऱ ऱ र व न श एव अन स ध न स स थ न JAWAHARLAL INSTITUTE OF POST GRADUATE MEDICAL EDUCATION & RESEARCH (स व स य एव ऩररव र कल य ण म त र ऱय, भ रत सरक र क अध न र ष ट र य महत व क स स थ न) (An Institution

More information

Case 3:15-cv PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )

Case 3:15-cv PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) Case 3:15-cv-05982-PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 Liza M. Walsh Christine I. Gannon CONNELL FOLEY LLP One Newark Center 1085 Raymond Boulevard, 19th Floor Newark, New Jersey

More information

Education. Current Activities

Education. Current Activities Nirali Mehta, M.Sc., M.Phil. Founder & Consultant Biostatistician Ahmedabad, Gujarat, India. M +91 9377060504 E nirali.mehta@pharma-stats.in W www.pharma-stats.in Education 1998-2001 Bachelor of Science

More information

Name of firm/applicant

Name of firm/applicant Recommendation:- The 18 th Subject Expert Committee (Oncology & Hematology) deliberated the proposals on 04.07.2014 and recommended the following:- Agenda no. Drug name Name of firm/applicant Recommendations

More information